Cardiovascular Morbidity and Mortality After Treatment of Hyperthyroidism | oneGRAVESvoice
Global Search
Global Search

Trusted Resources: Evidence & Education

Scientific literature and patient education texts

Back to Evidence & Education / Patient Education

Treatment-Induced Hypothyroidism Reduces Long-Term Post-Treatment Cardiovascular Morbidity and Mortality in Graves’ Disease and Toxic Multinodular Goiter

key information

source: Clinical Thyroidology

year: 2018

summary/abstract:

Hyperthyroidism is caused when the thyroid is overactive and produces too high of levels of thyroid hormones. The two most common causes of hyperthyroidism are Graves’ disease and toxic multinodular goiter. Antithyroid drugs, radioactive iodine therapy and surgery are all used to treat hyperthyroidism.

Thyroid hormones have major effects on the heart and palpitations and irregular heart rhythms are frequent symptoms caused by hyperthyroidism. Because of this, hyperthyroidism is associated with increased cardiac problems and can lead to death related to heart disease. This study examines the effect of radioactive iodine therapy and surgery on long-term heart disease outcomes in patients with Graves’ disease and toxic multinodular goiter and the relationship of these outcomes to post-treatment thyroid status.

 

read more

Related Content

To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close

Powered by

Brought to you by

Supported through an independent
educational grant by

© 2022 rareLife solutions Inc.